Bangladesh vs Cuba: The number of people with susceptibility test result for rifampicin
Bangladesh
43.54
in 2021
Cuba
40.43
in 2021
Bangladesh rank
121st
Cuba rank
124th
The number of people with susceptibility test result for rifampicin over time
- Bangladesh
- Cuba
How they compare
Bangladesh currently reports 43.54 against 40.43 in Cuba, a difference of 3.11.
That makes Bangladesh's figure about 1.1 times Cuba's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Cuba ahead.
Bangladesh ranks 121st and Cuba ranks 124th of 146 countries.
Cuba has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bangladesh | Cuba | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 26.1 | 66.38 | 40.28 | Cuba |
| 2020s | 39.25 | 45.55 | 6.29 | Cuba |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Bangladesh or Cuba?
- Bangladesh, at 43.54 against 40.43 in Cuba as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Bangladesh and Cuba?
- 3.11, with Bangladesh ahead.
- How many years of comparable data are there for Bangladesh and Cuba?
- 5 years are reported by both, from 2017 to 2021.
- How do Bangladesh and Cuba rank globally for the number of people with susceptibility test result for rifampicin?
- Bangladesh ranks 121st and Cuba ranks 124th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.